SonoScape Medical Corp
SZSE:300633

Watchlist Manager
SonoScape Medical Corp Logo
SonoScape Medical Corp
SZSE:300633
Watchlist
Price: 34.43 CNY -5.1% Market Closed
Market Cap: 14.8B CNY
Have any thoughts about
SonoScape Medical Corp?
Write Note

SonoScape Medical Corp
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SonoScape Medical Corp
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
SonoScape Medical Corp
SZSE:300633
Research & Development
-ÂĄ458.9m
CAGR 3-Years
-22%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Research & Development
-ÂĄ219.1m
CAGR 3-Years
-48%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Research & Development
-ÂĄ512.2m
CAGR 3-Years
-4%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Research & Development
-ÂĄ3.4B
CAGR 3-Years
-18%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Research & Development
-ÂĄ243.5m
CAGR 3-Years
-34%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Research & Development
-ÂĄ1.7B
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

SonoScape Medical Corp
Glance View

Market Cap
14.8B CNY
Industry
Health Care

Sonoscape Medical Corp. engages in the development and sale of medical equipment. The company is headquartered in Shenzhen, Guangdong and currently employs 2,156 full-time employees. The company went IPO on 2017-04-06. The firm's main products are medical ultrasound diagnostic equipment, such as color Doppler ultrasound diagnostic equipment and B-type ultrasound diagnostic equipment, medical electronic endoscope equipment and consumables, as well as blood analyzers.

Intrinsic Value
49.61 CNY
Undervaluation 31%
Intrinsic Value
Price

See Also

What is SonoScape Medical Corp's Research & Development?
Research & Development
-458.9m CNY

Based on the financial report for Sep 30, 2024, SonoScape Medical Corp's Research & Development amounts to -458.9m CNY.

What is SonoScape Medical Corp's Research & Development growth rate?
Research & Development CAGR 5Y
-14%

Over the last year, the Research & Development growth was -31%. The average annual Research & Development growth rates for SonoScape Medical Corp have been -22% over the past three years , -14% over the past five years .

Back to Top